MATHEW ABY J. (EVP & Chief Scientific Officer) reported 1 transaction at BIOLIFE SOLUTIONS INC
Review the transaction codes below to understand the nature of each event.
Filed: 3/23/2026ACC: 0001628280-26-020574
Officer· EVP & Chief Scientific Officer
Since Mar 2026
-2.25K
Net shares
Net seller
$43.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.25K
Price / share
$19.12
Trade value
$43.12K
% of position
0.6%
3/19/2026
392.94K→390.68K
Total
Net shares
−2.25K
Net value
-$43.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/19/2026 | F · Tax Withholding | −2.25K | $19.12 | $43.12K | 0.6% | 392.94K | 390.68K |
| Total | −2.25K | -$43.12K | ||||||
Derivative Transactions0
No derivative transactions reported